Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children
- PMID: 20154628
- DOI: 10.1097/GIM.0b013e3181d2af04
Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children
Abstract
The Secretary's Advisory Committee on Heritable Disorders in Newborns and Children is charged with evaluating conditions nominated for addition to the uniform screening panel and consequently making recommendations to the secretary of the US Department of Health and Human Services. This report describes the framework by which the committee approaches its task. Key decision nodes include initial review of every nomination to determine whether conditions are amenable for systematic evidence review, review of systematic evidence reviews conducted by the committee's external review group, and deliberation and formal recommendation for addition or exclusion to the uniform panel. Data analyzed include the accuracy and specificity of screening and diagnostic tests for nominated disorders, the extent of predicted health benefits, harms impact on disease course, and cost from early diagnosis and treatment. The committee process is guided by approaches used by similar entities, but more flexible criteria are sometimes needed to accommodate data limitations stemming from the rarity of many of these conditions. Possible outcomes of committee review range from recommendation to add a nominated condition to the uniform panel; provide feedback on specific gaps in evidence that must be addressed before making a decision; or rejection of a nomination (e.g., because of identified harms). The committee's structured evidence-based assessment of nominated conditions supports a consistently rigorous, iterative and transparent approach to its making recommendations regarding broad population-based screening programs for rare conditions in infants and children.
Comment in
-
Newborn screening--the unique role of unique evidence.Genet Med. 2010 Mar;12(3):160-1. doi: 10.1097/GIM.0b013e3181d19a57. Genet Med. 2010. PMID: 20139766 No abstract available.
Similar articles
-
Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.Genet Med. 2014 Feb;16(2):183-7. doi: 10.1038/gim.2013.98. Epub 2013 Aug 1. Genet Med. 2014. PMID: 23907646
-
Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review.Matern Child Health J. 2016 Mar;20(3):693-700. doi: 10.1007/s10995-015-1869-9. Matern Child Health J. 2016. PMID: 26833040 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.Genet Med. 2011 Oct;13(10):861-5. doi: 10.1097/GIM.0b013e3182209f09. Genet Med. 2011. PMID: 21716119
-
Universal newborn hearing screening: summary of evidence.JAMA. 2001 Oct 24-31;286(16):2000-10. doi: 10.1001/jama.286.16.2000. JAMA. 2001. PMID: 11667937 Review.
Cited by
-
A Systematic Review and Recommendations Around Frameworks for Evaluating Scientific Validity in Nutritional Genomics.Front Nutr. 2021 Dec 14;8:789215. doi: 10.3389/fnut.2021.789215. eCollection 2021. Front Nutr. 2021. PMID: 35004815 Free PMC article.
-
Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.Int J Neonatal Screen. 2023 Apr 6;9(2):20. doi: 10.3390/ijns9020020. Int J Neonatal Screen. 2023. PMID: 37092514 Free PMC article.
-
Iowa Newborn Screening Program Experience with Hemoglobinopathy Screening over the Last Two Decades and Its Increasing Global Relevance.Int J Neonatal Screen. 2024 Mar 8;10(1):21. doi: 10.3390/ijns10010021. Int J Neonatal Screen. 2024. PMID: 38535125 Free PMC article.
-
A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies.Int J Environ Res Public Health. 2020 Oct 30;17(21):8001. doi: 10.3390/ijerph17218001. Int J Environ Res Public Health. 2020. PMID: 33143182 Free PMC article.
-
Clinical utility of genetic and genomic services: context matters.Genet Med. 2016 Jul;18(7):672-4. doi: 10.1038/gim.2015.153. Epub 2015 Dec 10. Genet Med. 2016. PMID: 26656648 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical